“It violates the right to equal protection of transgender adolescents by singling out for prohibition only medical treatments that affirm a patient’s gender if inconsistent with that patient’s ‘biological sex’—thus prohibiting those treatments only for transgender minors,” stated the complaint. “The law is subject to heightened scrutiny because it classifies based on sex and because classifications based on transgender status are at least quasi-suspect.”
Boosted by Strong Demand in M&A and Private Equity, Revenue at Fredrikson & Byron Topped $300M
With a “good, strong, solid year” in 2025, the Midwest-centered